Trial · NCT02938468
Mgt of Chronic Subdural Hematoma Using Dexamethasone
NCT02938468, Phase 2, Phase 3, Unknown, University of Calgary
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mgt of Chronic Subdural Hematoma Using Dexamethasone. Trials, record NCT02938468. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02938468
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mgt of Chronic Subdural Hematoma Using Dexamethasone
- NCT number
- NCT02938468
- Status
- Unknown
- Phases
- Phase 2, Phase 3
- Enrollment
- 326 participants, estimated
- Lead sponsor
- University of Calgary
- Conditions
- Chronic Subdural Hematoma
- Interventions
- Dexamethasone, Any surgical intervention aim at treating chronic subdural hematoma
- First posted
- 2016-10-19
- Last updated
- 2020-07-01
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Failure rates | 3 months | Failure is defined as the requirement for surgical intervention in the dexamethasone group or re-operation in the surgical group. |
| Secondary | Recurrence rate | 3 months | Recurrence is defined as symptomatic and radiologic re-accumulation of subdural hematoma on the ipsilateral side requiring a reoperation within 3months after treatment. |
| Secondary | Modified Ranking Scale | 1, 3 and 6 months after treatment | Functional outcome |
| Secondary | Barthel index | 1, 3 and 6 months after treatment | Functional outcome |
| Secondary | Glasgow Outcome Scale | 1, 3 and 6 months after treatment | Functional outcome |
| Secondary | Glasgow Coma Scale | 1, 3 and 6 months after treatment | Functional outcome |
| Secondary | Markwalder score | 1, 3 and 6 months after treatment | Functional outcome |
| Secondary | Clinical improvement (Categorized as resolved, improved, unchanged or worse) | 1, 3 and 6 months after treatment | Categorized as resolved, improved, unchanged or worse |
| Secondary | Radiologic outcomes (Change in hematoma volume) | 1, 3 and 6 months after treatment | Measured as change in hematoma volume |
| Secondary | Quality of Life measured using the EQ-5D-5L | 1, 3 and 6 months after treatment | Quality of life will be measured using the EuroQol health survey (EQ-5D-5L) questionnaire. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02938468
GET https://conductscience.org/api/trials/v1/NCT02938468/registered